No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Food Distribution
O'will Corporation operates as a global enterprise, specializing in the import, export, and sale of food and beverage materials across Japan and internationally. Its extensive product range encompasses numerous food additives, such as vitamins, calcium, amino acids, emulsifiers, stabilizers, nutritional fortifiers, dietary fibers, and flavorings. The company also supplies various sweeteners, including high-fructose corn syrup, granulated sugar, fruit sugar, liquid sucrose, and refined white sugar. In the dairy sector, O'will provides a comprehensive selection of items, including pasteurized, concentrated, and powdered milk, cream, fermented milk, butter, and cheese. Its fruit and vegetable division offers juices, purees, fresh and frozen produce, canned goods, powders, and extracts. The beverage portfolio is diverse, featuring green, matcha, oolong, black, rooibos, and blended teas, alongside cocoa, herbal teas, and other drink options. Beyond food and beverages, O'will extends its offerings to industrial solutions, distributing wastewater treatment systems, smart ceiling fans, and specialized nozzle-type steam traps. Established in 1986, O'will Corporation is headquartered in Tokyo, Japan.
www.owill.co.jpNo one on the platform currently holds 3143.T.
No tracked institution reports a position in 3143.T as of their last filing.
No one on the platform has traded 3143.T yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 9.4% | 12.6% | — | — | — | |
| Rev. Growth % | 7.0% | 7.3% | ||||
| Profit Margin % | 1.9% | 2.1% | ||||
| Free Cash Flow Margin % | -2.8% | -0.8% | ||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $42.9B | -87.1% | $83.10 | $83.10–$83.10 | — | 1 |
| 2028 | $44.0B | +2.6% | $102.00 | $102.00–$102.00 | — | 1 |
| 2029 | $45.1B | +2.5% | $120.80 | $120.80–$120.80 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| +0.00% |
| $2776 |
| — |
| 4925.THABA Laboratories,Inc. | $1735.00 | +0.00% | $6.6B | — |
| 4934.TPremier Anti-Aging Co., Ltd. | $601.00 | -1.48% | $5.2B | — |
Source: Financial Modeling Prep · peers by sector/industry